COVID-19: Who will produce the vaccine? 
Aldo Tagliabue and Guido Forni
As the coronavirus pandemic (COVID-19) sweeps through many parts of world, many attempts are being made to develop methodologies to induce protective immunity against the virus infection. Different pathways are being employed: using vaccines to induce prophylactic antibodies and cellular reactivity, transferring plasma containing antibodies from convalescent patients, or administering monoclonal antibodies specifically induced against SARS-CoV-2. The development of a safe vaccine, effective in preventing infection and inexpensive, seem to be the only way to control the pandemic, thus allowing us to resume our normal daily activities and progressively mitigate the social and economic problems that we are struggling with (Cecconi et al, 2020).
Read more
approved by Covid-19 Committee / approvato dalla Commissione Covid-19